PMID: 9554559Apr 29, 1998Paper

Mechanisms of insulin-like growth factor-I-induced accelerated recovery in experimental ischemic acute renal failure

Mineral and Electrolyte Metabolism
R Hirschberg, H Ding

Abstract

Exogenous administration of recombinant human insulin-like growth factor I (rhIGF-I) to normal rats or humans increases renal blood flow and glomerular filtration rate (GFR). In rats with ischemic acute renal failure (iARF) the peptide accelerates the recovery of renal function and tubular integrity. These latter effects may be caused by renal hemodynamic actions of IGF-I or may result from direct actions of IGF-I on injured tubular cells. To examine this hypothesis, in vivo studies were performed in rats with iARF and in vitro experiments were conducted using a model of anoxia/reoxygenation injury in primary cultures of rat proximal tubular cells. In rats with iARF, IGF-I ameliorates the rise in serum creatinine, improves GFR, increases the rate of bromodeoxyuridine (BrdU) incorporation and the mitosis score, and reduces the number of apoptotic bodies. In acutely injured proximal tubular cells, IGF-I receptor mRNA levels decrease, but the remaining receptors are functional as indicated by ligand-induced phosphorylation of the IGF-I receptor beta-subunit. In anoxia/reoxygenation-injured cells, exogenous rhIGF-I improves ATP repletion, increases 3H-thymidine and BrdU incorporation and reduces the incidence of apoptosis as determ...Continue Reading

Citations

May 29, 2002·Life Sciences·I Ibáñez de CáceresM A Villanúa
Feb 19, 2002·Kidney International·Nestor Schor
Jun 27, 2002·Transplantation·Marc A R C DaemenWim A Buurman
Nov 26, 2003·Current Opinion in Critical Care·An S De Vriese, Marc Bourgeois
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·D E VarlamH Rüssmann
Sep 16, 1999·The Journal of Clinical Investigation·M A DaemenW A Buurman
Sep 1, 2011·Kidney International Supplements·Barbara ImbertiAriela Benigni
May 19, 2010·The Journal of Urology·Hiroshi AsanumaKirstan K Meldrum
Mar 2, 2005·Annales Françaises D'anesthèsie Et De Rèanimation·N Lameire
Aug 3, 1999·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·J Isgaard, A Tivesten
Jul 19, 2011·The American Journal of Pathology·Maliha A AlikhanSharon D Ricardo
May 4, 2016·International Urology and Nephrology·Sabine Brandt, P R Mertens
Oct 19, 2007·Journal of the American Society of Nephrology : JASN·Barbara ImbertiGiuseppe Remuzzi
Jan 25, 2019·Science Translational Medicine·Guillaume CanaudJoseph V Bonventre
Sep 3, 2005·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Silvio TucciJose E S Roselino
Apr 25, 2014·Journal of Cellular and Molecular Medicine·Liping LiTongyu Zhu
Sep 11, 2004·The Journal of Biological Chemistry·Kwon Moo ParkJoseph V Bonventre
Jan 27, 2018·Journal of the American Society of Nephrology : JASN·Alexander L KolbRobert L Bacallao
Mar 28, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Qin YangXiao-Ming Meng
Feb 22, 2003·Journal of the American Society of Nephrology : JASN·An S De Vriese

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.